Frontiers in Pharmacology | Pharmacoepidemiology

Original Research

Published on 22 Sep 2023

Evaluation of a clinical pharmacist-led antimicrobial stewardship program in a neurosurgical intensive care unit: a pre-and post-intervention cohort study

in Pharmacoepidemiology

Jing Yu
Yan Liu
Ruochen Qu
Ziyang Wang
Yan Zhao
Yuanyuan Zhao
Chunhua Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1263618

3,250 views
3 citations

Original Research

Published on 20 Sep 2023

Translation and validation of the Sindhi version of the general medication adherence scale in patients with chronic diseases

in Pharmacoepidemiology

Md. Ashraful Islam
Wajiha Iffat
Shahlla Imam
Sadia Shakeel
Abdul Rasheed
Atta Abbas Naqvi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1235032

2,065 views
3 citations

Original Research

Published on 18 Sep 2023

Cardiovascular adverse effects associated with the use of anti-HER2 in breast cancer treatment

in Pharmacoepidemiology

Patricia Marques Soares Valente
Paula Nogueira da Silva
Licínio Esmeraldo da Silva
Wolney de Andrade Martins
Selma Rodrigues de Castilho

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1099545

1,565 views
2 citations

Original Research

Published on 15 Sep 2023

Effectiveness and safety of oral anticoagulants for non-valvular atrial fibrillation: a population-based cohort study in primary healthcare in Catalonia

in Pharmacoepidemiology

Maria Giner-Soriano
Dan Ouchi
Roser Vives
Carles Vilaplana-Carnerero
Andrea Molina
Antoni Vallano
Rosa Morros

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237454

2,290 views
3 citations

Original Research

Published on 14 Sep 2023

Epirubicin and gait apraxia: a real-world data analysis of the FDA Adverse Event Reporting System database

in Pharmacoepidemiology

Wei Wang
Xin Guan
Shuang Wang
Lipeng Shi
Yanfei Zhu
Pengbo Hua
Qiang Guo
Jingqi Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1249845

2,390 views
2 citations

Original Research

Published on 14 Sep 2023

Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system

in Pharmacoepidemiology

Rui Xiong
Jing Lei
Sicen Pan
Hong Zhang
Yongtao Tong
Wei Wu
Yi Huang
Xiaodan Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226086

2,766 views
4 citations

Editorial

Published on 12 Sep 2023

Editorial: Women in pharmacoepidemiology: 2021

in Pharmacoepidemiology

Luciane Cruz Lopes
Daniela C. Moga
Tatiane Da Silva Dal Pizzol
Natasa Gisev
Bita Mesgarpour
Anick Bérard

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1278768

1,308 views

Original Research

Published on 07 Sep 2023

Association between marijuana use and kidney stone: a cross-sectional study of NHANES 2009 to 2018

in Pharmacoepidemiology

Xingpeng Di
Liyuan Xiang
Menghua Wang
Xin Wei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1214647

35,609 views
2 citations

Review

Published on 23 Aug 2023

Multisystem inflammatory syndrome drug treatment in countries with different income profiles: a scoping review

in Pharmacoepidemiology

Luis Phillipe Nagem Lopes
Lidiane Gomes da Cunha
Alice Ramos Oliveira Silva
Marcelo Gerardin Poirot Land
Adriana Rodrigues Fonseca
Luciane Cruz Lopes
Elisangela Costa Lima

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1228986

1,866 views
1 citation

Original Research

Published on 17 Aug 2023

Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis

in Pharmacoepidemiology

Carlos E. Durán
Judit Riera-Arnau
Shahab Abtahi
Romin Pajouheshnia
Vjola Hoxhaj
Magdalena Gamba
Ema Alsina
Mar Martin-Perez
Patricia Garcia-Poza
Ana Llorente-Garcia

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1207976

4,448 views
4 citations

General Commentary

Published on 16 Aug 2023

Commentary: Adverse event profiles of PARP inhibitors: analysis of spontaneous reports submitted to FAERS

in Pharmacoepidemiology

Jeanne M. Schilder
Amanda Golembesky
Tirza Areli Calderón Boyle
Gui Lan Ye
Judi Kuplast

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1241524

2,763 views
6 citations

Original Research

Published on 14 Aug 2023

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system

in Pharmacoepidemiology

Wei Wei
Li Chen
Hui Zhou
Jinfeng Liu
Yue Zhang
Shiyu Feng
Yingtao Bai
Yanen Leng
En Chang
Liang Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1208456

8,382 views
9 citations

Original Research

Published on 10 Aug 2023

Using administrative healthcare data to evaluate drug repurposing opportunities for cancer: the possibility of using beta-blockers to treat breast cancer

in Pharmacoepidemiology

George S. Q. Tan
Edoardo Botteri
Stephen Wood
Erica K. Sloan
Jenni Ilomäki

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1227330

2,271 views

Systematic Review

Published on 27 Jul 2023

Efficacy of opioids for traumatic pain in the emergency department: a systematic review and Bayesian network meta-analysis

in Pharmacoepidemiology

Yawen Fu
Qiang Liu
Hu Nie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209131

3,612 views
2 citations

Original Research

Published on 24 Jul 2023

Characteristic analysis of adverse reactions of five anti-TNFɑ agents: a descriptive analysis from WHO-VigiAccess

in Pharmacoepidemiology

Mingming Li
Ruxu You
Yuyong Su
Hongbo Zhou
Shiwei Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1169327

5,876 views
11 citations

Original Research

Published on 18 Jul 2023

Opioid prescription patterns in the province of Las Palmas, Canary Islands, Spain (2016–2020): differences between urban and rural areas

in Pharmacoepidemiology

Alexis Oliva
Patricia González de Chavez
Sandra Dévora
Susana Abdala

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1184457

3,106 views
2 citations